Vertex Pharmaceuticals
(NASDAQ:VRTX)
$299.23
-3.77[-1.24%]
At close: Aug 17
$299.23
After Hours: 4:05PM EDT
Day High/Low298.79 - 302.82
52 Week High/Low214.66 - 305.95
Open / Close300.04 / 299.23
Float / Outstanding- / 256.5M
Vol / Avg.908.6K / 1.6M
Mkt Cap76.7B
P/E24.53
50d Avg. Price281.41
Div / Yield-
Payout Ratio-
EPS3.17
Total Float256.1M

Vertex Pharmaceuticals (NASDAQ:VRTX), Quotes and News Summary

Vertex Pharmaceuticals (NASDAQ: VRTX)

Day High/Low298.79 - 302.82
52 Week High/Low214.66 - 305.95
Open / Close300.04 / 299.23
Float / Outstanding- / 256.5M
Vol / Avg.908.6K / 1.6M
Mkt Cap76.7B
P/E24.53
50d Avg. Price281.41
Div / Yield-
Payout Ratio-
EPS3.17
Total Float256.1M
Sector: Health Care.Industry: Biotechnology
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-01
REV
Q2 2022Est.ActualSurprise
EPS3.5203.600 0.0800
REV2.130B2.196B66.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Vertex Pharmaceuticals Questions & Answers

Q
How do I buy Vertex Pharmaceuticals (VRTX) stock?
A

You can purchase shares of Vertex Pharmaceuticals (NASDAQ: VRTX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Vertex Pharmaceuticals's (VRTX) competitors?
Q
What is the target price for Vertex Pharmaceuticals (VRTX) stock?
A

The latest price target for Vertex Pharmaceuticals (NASDAQ: VRTX) was reported by Piper Sandler on Wednesday, August 17, 2022. The analyst firm set a price target for 288.00 expecting VRTX to fall to within 12 months (a possible -3.75% downside). 23 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Vertex Pharmaceuticals (VRTX)?
A

The stock price for Vertex Pharmaceuticals (NASDAQ: VRTX) is $299.23 last updated August 17, 2022, 8:00 PM UTC.

Q
Does Vertex Pharmaceuticals (VRTX) pay a dividend?
A

There are no upcoming dividends for Vertex Pharmaceuticals.

Q
When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?
A

Vertex Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 1, 2022.

Q
Is Vertex Pharmaceuticals (VRTX) going to split?
A

There is no upcoming split for Vertex Pharmaceuticals.

Q
What sector and industry does Vertex Pharmaceuticals (VRTX) operate in?
A

Vertex Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.